France Active Pharmaceutical Ingredients (API) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The France Active Pharmaceutical Ingredients (API) Market is Segmented by Business Mode (Captive API and Merchant API), Synthesis Type (Synthetic and Biotech), Drug Type (Generic and Branded), and Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other Applications). The report offers the value (in USD billion) for the above segments.

France Active Pharmaceutical Ingredients (API) Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

France Active Pharmaceutical Ingredients (API) Industry Overview

The French Active Pharmaceutical Ingredients market is fairly fragmented, with the presence of several key players in the market. Several companies are adopting various business strategies such as collaboration, facility expansion, partnerships, and product launches to withhold their market position. Some of the key players in the market are Viatris Inc., Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis AG, BASF SE, and Merck KGaA, among others.

France Active Pharmaceutical Ingredients (API) Market Leaders

  1. Pfizer Inc.

  2. Novartis AG

  3. BASF SE

  4. Viatris Inc.

  5. Merck KGaA

  6. *Disclaimer: Major Players sorted in no particular order
France Active Pharmaceutical Ingredients Market - cl.png